Abstract
Introduction
Although the etiology of polycystic ovary syndrome (PCOS) has not yet been fully elucidated, it is thought to be multifactorial. One of the debated mechanisms is the increase in oxidative stress. However, findings regarding oxidative stress increase in adolescents are inconsistent in the literature. This study aimed to evaluate oxidative stress parameters in adolescents with PCOS.
Materials and Methods
Adolescent girls aged 12-18 years, who presented to our Adolescent Health Outpatient Clinic between September 2021 and March 2023 and had menarche at least two years prior, were included in the study. Adolescents diagnosed with PCOS were included in the study group, while age- and body mass index (BMI)-matched healthy adolescents were included in the control group. A medical and menstrual history was obtained from all participants, and physical examinations were performed. Hormonal tests were conducted to assess PCOS diagnosis and hyperandrogenism, C-reactive protein (CRP) levels were measured to evaluate inflammation, and oxidative stress parameters were assessed by measuring native thiol, total thiol, and ischemia-modified albumin (IMA) levels. Additionally, disulfide levels, disulfide/native thiol ratio, disulfide/total thiol ratio, and native thiol/total thiol ratio were calculated.
Results
The study included 33 adolescents with PCOS and 43 healthy adolescents. No significant differences were found between the PCOS and control groups in terms of oxidative stress parameters or IMA levels. Correlation analysis revealed negative correlations between native thiol-total thiol levels and BMI, waist circumference, systolic blood pressure, diastolic blood pressure, and CRP.
Conclusion
In our study, no statistically significant difference was found in oxidative stress parameters between the PCOS and control groups. On the other hand, an inverse relationship was observed between antioxidant capacity and metabolic and inflammatory parameters. Considering the significant association reported in adult PCOS studies, these findings suggest that increased oxidative stress may be a consequence that becomes more pronounced with aging rather than a primary factor in the etiology of PCOS.
Keywords: Polycystic ovary syndrome, oxidative stress, adolescence
References
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28-38.
Naz MSG, Tehrani FR, Majd HA, Ahmadi F, Ozgoli G, Fakari FR, et al. The prevalence of polycystic ovary syndrome in adolescents: a systematic review and meta-analysis. Int J Reprod Biomed. 2019;17:533-42.
Ibáñez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, et al. An International consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88:371-95.
Bahreiny SS, Ahangarpour A, Saki N, Dabbagh MR, Ebrahimi R, Mahdizade AH, et al. Association of free radical product and polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Sci. 2024;31:1486-95.
Erel Ö, Erdoğan S. Thiol-disulfide homeostasis: an integrated approach with biochemical and clinical aspects. Turk J Med Sci. 2020;50:1728-38.
Mengen E, Uçaktürk SA, Kocaay P, Kaymaz Ö, Neşelioğlu S, Erel Ö. The significance of thiol/disulfide homeostasis and ischemia-modified albumin levels in assessing oxidative stress in obese children and adolescents. J Clin Res Pediatr Endocrinol. 2020;12:45-54.
Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47:326-32.
Gaze DC. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet. 2009;24:333-41.
Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22:3789.
Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril. 2003;80:123-7.
Murri M, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19:268-88.
Demirel F, Bideci A, Cinaz P, Camurdan MO, Biberoğlu G, Yesilkaya E, et al. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2007;67:129-34.
Fulghesu A, Magnini R, Portoghese E, Angioni S, Minerba L, Melis GB. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome. J Adolesc Health. 2010;46:474-81.
Karadeniz M, Erdoğan M, Tamsel S, Zengi A, Alper GE, Cağlayan O, et al. Oxidative stress markers in young patients with polycystic ovary syndrome, the relationship between insulin resistances. Exp Clin Endocrinol Diabetes. 2008;116:231-5.
Witchel SF, Oberfield S, Rosenfield RL, Codner E, Bonny A, Ibáñez L, et al. The diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015.
Martin KA, Anderson RR, Chang RJ, Ehrmann DA, Lobo RA, Murad MH, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:1233-57.
Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society. Hum Reprod Update. 2012;18:146-70.
Ibáñez L, de Zegher F. Adolescent PCOS: a postpubertal central obesity syndrome. Trends Mol Med. 2023;29:354-63.
Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010;203:201.
Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med. 2000;19:311-5.
Sen B, Gonultas S, Albayrak C, Temur S, Acar I, Ozkan BN, et al. Evaluation of oxidative stress and inflammation in patients with polycystic ovary syndrome. Obstet Gynecol Sci. 2024;67:414-20.
Laleli B, Timur B. Examination of oxidative stress level in adolescents with polycystic ovary syndrome by biochemical parameters. Gümüşhane Sağlık Bilimleri Dergisi. 2021;10:935-42.
Aydın GA, Turan Özsoy HG, Ankaralı H, Özgen G, Neşelioğlu S. The association of dynamic thiol-disulfide homeostasis and inflammatory markers in patients with polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2020;59:79-84.
Siemers KM, Klein AK, Baack ML. Mitochondrial dysfunction in PCOS: insights into reproductive organ pathophysiology. Int J Mol Sci. 2023;24:13123.
Yildirim M, Turkyilmaz E, Neselioglu S, Alisik M, Avsar AF. Dynamic thiol-disulphide status in polycystic ovary syndrome and its association with the pathogenesis of the disease. Gynecol Obstet Invest. 2017;82:54-9.
Ozler S, Oztas E, Tokmak A, Ergin M, Isci E, Eren F, et al. The association of thiol/disulphide homeostasis and lipid accumulation index with cardiovascular risk factors in overweight adolescents with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2016;84:516-23.
Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril. 2011;95:1048-58.
Khashchenko E, Vysokikh M, Uvarova E, Krechetova L, Vtorushina V, Ivanets T, et al. Activation of systemic inflammation and oxidative stress in adolescent girls with polycystic ovary syndrome in combination with metabolic disorders and excessive body weight. J Clin Med. 2020;9:1399.
Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, et al. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2014;30:781-4.
